All Stories

  1. Polyherbal Formulation Attenuates Isoproterenol-Induced Cardiac Toxicity Through Regulation of Mitochondrial Bioenergetics, Lipid Toxicity, and Intrinsic Apoptotic Pathways in Rats
  2. Epithelial–mesenchymal transition and cancer-associated fibroblasts in tumor progression and therapy resistance: mechanistic convergence and therapeutic opportunities
  3. Toxicomicrobiomics: Unveiling the Role of Human Microbiome in Drug and Xenobiotic Metabolism
  4. Advancement in CAR T-Cell Therapy in Tumors
  5. Adverse Effects of CAR T-Cell Therapy and Management: Cytokine Release Syndrome and Neurotoxicity
  6. Clinical Success of CAR T Cells in Hematologic Cancers: Lessons from Leukemia and Lymphoma
  7. Combining CAR T Cells with Immunotherapies to Enhance Treatment Effectiveness
  8. Engineering CAR T Cells: Advances in Vector Design and Gene Editing
  9. From Bench to Bedside: Innovations and Challenges in CAR-T Cell Therapy Manufacturing and Regulation
  10. History and Evolution of CAR T-Cell Therapy
  11. Next-Generation CARs and Beyond: Synthetic Biology and Logic-Gates in Next-Generation CARs
  12. Optimizing CAR T-Cell Efficacy: Enhancing Proliferation, Persistence, and Memory
  13. Overcoming Challenges of CAR T-Cell Therapy in Solid Tumor Microenvironments
  14. Personalized CAR T-Cell Therapy: Tailoring to Patient-Specific Tumors
  15. Regulatory Landscape and Challenges in CAR-T Cell Therapy Development and Clinical Trials
  16. Biomarkers for targeted therapy and treatment decision making
  17. Cancer biomarker that are currently used in cancer therapy and under evaluation in clinical trials
  18. Biomarkers for cancer screening, diagnosis and targeted therapeutic approaches
  19. Classification of cancer biomarkers based on treatment strategies
  20. Future perspectives and challenges for identification and recognition of clinically significant cancer biomarkers
  21. Patient-centric approaches and personalized nanomedicine in skin cancer
  22. Combination of hydroxycitric acid and capsaicin regulates IRS-1/AMPK-mTOR-SREBP-1c Axis/NLRP3-NF-κB/Nrf-2-ARE signaling pathways to ameliorate the two-hit process in high-fat diet-induced hepatic steatosis
  23. Integrating CAR-T cells with other Immunotherapies for improved efficacy in cancer patients
  24. The Mediating Role of the Gut Microbiome in the Nutritional Prevention of Cancer
  25. Activated protein C promotes human lung cancer progression through the release of tumor extracellular vesicles and transfer of microRNA-200a
  26. Application and Prospects of Nanotechnology for Water Treatment
  27. Current Status and Future Prospects of Nanotechnology in the Healthcare Industry
  28. Regulatory dynamics of Th17 lymphocytes in oral squamous cell carcinoma: immune modulation and emerging immunotherapies
  29. Tumor microenvironment in breast cancer: cellular crosstalk, pathways, and therapeutic insights
  30. Molecular approaches of phytoremediation – a strategic regulator for pollution management
  31. Dissecting dietary hazards: cytogenotoxic impacts of monosodium glutamate, baking powder, and citric acid using Allium cepa assay
  32. Extracellular vesicles in acute myeloid leukemia: The role in disease pathogenesis, potential biomarker, and application in clinical settings
  33. Natural Products and their Bioactive Compounds for the Prevention and Treatment of Diabetes Mellitus: A Systematic Review
  34. Prevalence of Cancer in India with Respect to Leukaemia and their Factorial Relations
  35. Nanoplatforms for precision imaging and targeted therapy in oncology
  36. Beyond coagulation: Coagulation protease factor VIIa in cytoprotective response
  37. Frontiers in superbug management: innovating approaches to combat antimicrobial resistance
  38. Detection Methods in HPV-Related Cancers
  39. CAR T-Cell Therapies against Viral Oncogenesis
  40. Cytomegalovirus (CMV)
  41. Difficulties in Promptly Diagnosing and Treating Neonatal Herpes Simplex Virus Infection
  42. Global Epidemiology of Oncogenic Viral Infections
  43. Hepatitis B Virus Infection
  44. Host–Viral Interactions during Oncogenic Infections
  45. Human T-Cell Leukemia Virus (HTLV)-Induced Carcinogenesis and Its Molecular Detection
  46. Immune Response Associated with Oncogenic Viral Diseases
  47. Laboratory Animal Model for Oncogenic Virus
  48. Malignant Transformation In Vitro by Oncogenic Viruses
  49. Molecular Cancer Drug Discovery
  50. Types of Viral Oncogenic Viral Diseases
  51. Vaccines
  52. Viral Oncology
  53. Evaluation of Bloodstream Infections Associated with Carbapenem-Resistant Enterobacteriaceae in Paediatric and Adult Patients
  54. Epigenetic analysis in cancer research
  55. Gene therapies for neurodegenerative disease: current knowledge and challenges
  56. Gene therapy under clinical trials for neurodegenerative diseases
  57. Introduction to cancer biology and current research trends
  58. Transgene delivery system: viral, nonviral, and other methods for central nervous system
  59. Emerging biomarkers for non-invasive cancer diagnosis and treatment
  60. Metabolomics-Driven Biomarker Discovery for Breast Cancer Prognosis and Diagnosis
  61. Method Optimization and Validation of Antibiotics Residues in Milk Sample Using LC-MS/MS
  62. The role of extracellular vesicles in the pathogenesis of gynecological cancer
  63. MicroRNAs in extracellular vesicles: A potential role in cancer progression
  64. Development of New Screening Methods for SARS CoV 2 and its Associated Developing Variations
  65. Diagnosis and Treatment of Health Effects Caused by Airborne Contaminants
  66. Development of Personalized Medicine
  67. Nanobiotechnology in Personalized Oncology
  68. Phytoformulation with hydroxycitric acid and capsaicin protects against high-fat-diet-induced obesity cardiomyopathy by reducing cardiac lipid deposition and ameliorating inflammation and apoptosis in the heart
  69. Astroviruses: Overview and Emerging Disease
  70. Molecular Mechanisms of Human Papillomavirus-Induced Cervical Carcinogenesis
  71. Immunogenicity of cancer cells: An overview
  72. Risk Prediction and Diagnosis of Breast Cancer Using ML Algorithms
  73. CAR T-cell therapy: Reprogramming patient's immune cell to treat cancer
  74. An Updated Review on Influenza Viruses
  75. Avian Influenza: A Potential Threat to Human Health
  76. Crimean-Congo Haemorrhagic Fever Virus: A Complete Overview
  77. Novel Diagnostic Methods for Emerging Respiratory Viral Infection
  78. RAS: Circuitry and therapeutic targeting
  79. Effect of Allium Sativum on the Alcohol Induced Neuropathic Pain in Wistar Rats
  80. Cardiovascular Diseases and Nutraceuticals: Underlying Mechanism and Therapeutic Biomarkers
  81. Epigenetic Regulation of Breast Cancer
  82. Microbial indicators and methods for source tracking faecal contamination of groundwater
  83. Mesenchymal stem cells in SARS-CoV-2 infection: A hype or hope
  84. Expression profile of MUC1 protein in Pigeon allergens positive asthmatic
  85. Current updates on adaptive immune response by B cell and T cell stimulation and therapeutic strategies for novel coronavirus disease 2019 (COVID-19) treatment
  86. Phytopharmaceuticals in Cancer Treatment
  87. Epigenetic Regulation of Breast Cancer
  88. Research Article Non-synonymous de novo gene mutations in Wilms’ Tumor: Identification and characterization of new variants of WT1 and WT2 loci in Indian Population
  89. Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM+CD45+ phenotype
  90. Reversal of hypermethylation and reactivation of glutathione S-transferase pi 1 gene by curcumin in breast cancer cell line
  91. Breast cancer and human papillomavirus infection: No evidence of HPV etiology of breast cancer in Indian women